Citation Impact
Citing Papers
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
2009
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Differential Roles of NR2A- and NR2B-Containing NMDA Receptors in Activity-Dependent Brain-Derived Neurotrophic Factor Gene Regulation and Limbic Epileptogenesis
2007
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Evidence that nitric oxide mediates the cyclic GMP response to synaptic activity in the rat superior cervical ganglion
1992 StandoutNobel
Nitric oxide synthases: regulation and function
2011 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle
1993 StandoutNobel
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Glutamate uptake
2001 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
2012
Alzheimer's disease
2011 Standout
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
2011 Standout
Epidemiology of Alzheimer disease
2011
Microglial cell origin and phenotypes in health and disease
2011 Standout
Neuronal sensitivity to hyperoxia, hypercapnia, and inert gases at hyperbaric pressures
2003 StandoutNobel
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Mitochondrial Etiology of Neuropsychiatric Disorders
2017
Targeted disruption of the neuronal nitric oxide synthase gene
1993 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Induction of astrocyte glutamine synthetase activity by the lathyrus toxin β‐N‐oxalyl‐L‐α,β‐diaminopropionic acid (β‐L‐ODAP)
1993
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Glutamate, nitric oxide and cell-cell signalling in the nervous system
1991 Standout
Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase
1991 StandoutNobel
Nitric oxide synthase in ferret brain: localization and characterization
1992 StandoutNobel
Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains
1996 Standout
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Heterogeneity and Functional Properties of Subtypes of Sodium-Dependent Glutamate Transporters in the Mammalian Central Nervous System
1996
Adiposity and Alzheimer's disease
2008
Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage
1992
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Apolipoprotein E in Alzheimer's disease and other neurological disorders
2011
Inositol 1,4,5-Trisphosphate receptor causes formation of ER cisternal stacks in transfected fibroblasts and in cerebellar purkinje cells
1994 StandoutNobel
Effect of MK-801 on Seizures Induced by Exposure to Hyperbaric Oxygen: Comparison with AP-7
1998
Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain
2014
Alzheimer's Disease
2010 Standout
Neuronal Calcium Signaling
1998 Standout
PPARγ agonists as new therapeutic agents for the treatment of Alzheimer's disease
2006
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
The Pathobiology of Vascular Dementia
2013 Standout
Induction of brain derived neurotrophic factor mRNA by seizures in neonatal and juvenile rat brain
1997
Pharmacological tools for the investigation of metabotropic glutamate receptors (mGluRs): Phenylglycine derivatives and other selective antagonists—an update
1995
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
The projected effect of risk factor reduction on Alzheimer's disease prevalence
2011 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
2008 StandoutNobel
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Nitric Oxide: A Physiologic Mediator of Penile Erection
1992 StandoutScience
Neurotrophins: Roles in Neuronal Development and Function
2001 Standout
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
1991 Standout
Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
2007
A Century of Alzheimer's Disease
2006 StandoutScience
Genetic variation at a single locus and age of onset for Alzheimer's disease
2010
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
2015
XIV. International Union of Pharmacology Nomenclature in Nitric Oxide Research
1997 StandoutNobel
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
The possible role of hydrogen sulfide as an endogenous neuromodulator
1996 Standout
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems
1992
Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues.
1991 Standout
Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease
2006
Caged nitric oxide. Stable organic molecules from which nitric oxide can be photoreleased.
1994 StandoutNobel
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Modulation of receptor-mediated inositol phospholipid breakdown in the brain
1991
Existence of nitric oxide synthase in rat hippocampal pyramidal cells.
1994 StandoutNobel
Nitric oxide as a secretory product of mammalian cells
1992 Standout
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
1997 Standout
Adiposity, Type 2 Diabetes, and Alzheimer's Disease
2009
Works of George C. Ormandy being referenced
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
2006
Analysis of the convulsant-potentiating effects of lithium in rats
1991
Dibenzocycloalkenimine (MK-801) stimulates phosphoinositide hydrolysis in rat cerebral cortical slices
1990
Inhibition of excitatory amino acid-stimulated phosphoinositide hydrolysis in rat hippocampus by l-aspartate-β-hydroxamate
1992
Inhibition of phosphoinositide hydrolysis by the novel neurotoxinβ-N-oxalyl-l-α, β-diaminopropionic acid (l-BOAA)
1990
Sodium nitroprusside and guanosine 3′,5′-monophosphate (cyclic GMP) inhibit stimulated phosphoinositide hydrolysis in rat cerebral cortical slices
1989
Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats
1989